NCT03207308

Brief Summary

Despite economic growth in developing countries, Sub-Saharan Africa still faces food insecurity malnutrition and infections. Micronutrient deficiency and infectious diseases still remain a public health problem and have a negative impact on health and the economy. They are both directly and indirectly responsible for children morbidity and mortality. Due to high level of children mortality (139‰) Vitamin A Supplementation (VAS) program was implemented in Senegal since 1999. A national representative study undertook in 2010 to have biological data on vitamin status and infections, showed that 24.4% of children aged 1-5 y were Vitamin A Deficiency (VAD) and 50.2% were infected. To address VAD issue, large scale oil fortification was launched by government and private industries also fortified bouillon cubes. Furthermore, home fortification is being initiated without evaluation of VAD control strategies existing in the country. In order to assess the impact of national VAD control strategies in Senegalese children, this study was designed to measure in subsample of rural children aged 3-5 y, the current vitamin A total body stores in relation to their infectious status.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
55

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 24, 2017

Completed
10 days until next milestone

Study Start

First participant enrolled

February 3, 2017

Completed
5 months until next milestone

First Posted

Study publicly available on registry

July 2, 2017

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 15, 2017

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2017

Completed
Last Updated

February 26, 2019

Status Verified

February 1, 2019

Enrollment Period

6 months

First QC Date

January 24, 2017

Last Update Submit

February 22, 2019

Conditions

Keywords

Vitamin A StatusRetinol Isotope dilutionTotal body vitamin A storesChildrenSenegal

Outcome Measures

Primary Outcomes (1)

  • Vitamin A status 1

    Total body pool size vitamin A (mmol)

    Within the coming 2 years

Secondary Outcomes (11)

  • Acute infection

    Within the coming 2 years

  • Chronic infection

    Within the coming 2 years

  • Iron status

    Within the coming 2 years

  • Stunting

    Within the coming 2 years

  • Wasting

    Within the coming 2 years

  • +6 more secondary outcomes

Study Arms (1)

Vitamin A supplementation

EXPERIMENTAL

55 children will receive a Mega-dose of preformed Vitamin A as recommended by the Senegalese Ministry of Health

Dietary Supplement: Vitamin A supplementation

Interventions

Vitamin A supplementationDIETARY_SUPPLEMENT

200,000 IU of preformed vitamin A

Vitamin A supplementation

Eligibility Criteria

Age3 Years - 5 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • years, not planning to move from the study area for the duration of the study, and do not have severe illness at the time of enrollment.

You may not qualify if:

  • severe anaemia, severe acute malnutrition, obesity or clinically defined severe illness, such as dehydration, severe diarrhoea or severe respiratory illness.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universite Cheikh Anta Diop

Dakar, Senegal

Location

MeSH Terms

Conditions

Infections

Study Officials

  • Cornelia Loechl, PhD

    International Atomic Energy Agency

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 24, 2017

First Posted

July 2, 2017

Study Start

February 3, 2017

Primary Completion

August 15, 2017

Study Completion

December 1, 2017

Last Updated

February 26, 2019

Record last verified: 2019-02

Data Sharing

IPD Sharing
Will not share

Locations